Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 9, 2007
Modulating co-stimulation
Vissia Viglietta, Samia J Khoury
Seminars in Immunology
|
March 24, 2004
Human CD4+CD25+ regulatory T cells
Clare Baecher-Allan, Vissia Viglietta, David A Hafler
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
Inhibition of human CD4(+)CD25(+high) regulatory T cell function
Clare Baecher-Allan, Vissia Viglietta, David A Hafler
The Journal of Clinical Investigation
|
April 3, 2002
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes
Vissia Viglietta, Sally C Kent, Tihamer Orban, et al.
The Journal of Experimental Medicine
|
April 7, 2004
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
Vissia Viglietta, Clare Baecher-Allan, Howard L Weiner, et al.
Clinical Therapeutics
|
May 23, 2015
Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate
John O'Gorman, Heidy K Russell, Jie Li, et al.
International Journal of MS Care
|
June 3, 2016
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Jonathan Calkwood, Timothy Vollmer, Robert J Fox, et al.
The Lancet. Neurology
|
March 15, 2011
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni, Stuart Cook, Kottil Rammohan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2005
Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells
Sally C Kent, Yahua Chen, Sue M Clemmings, et al.
Investigational New Drugs
|
March 12, 2020
Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients
Vissia Viglietta, Fuxin Shi, Qi-Ying Hu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 9, 2007
Modulating co-stimulation
Vissia Viglietta, Samia J Khoury
Seminars in Immunology
|
March 24, 2004
Human CD4+CD25+ regulatory T cells
Clare Baecher-Allan, Vissia Viglietta, David A Hafler
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
Inhibition of human CD4(+)CD25(+high) regulatory T cell function
Clare Baecher-Allan, Vissia Viglietta, David A Hafler
The Journal of Clinical Investigation
|
April 3, 2002
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes
Vissia Viglietta, Sally C Kent, Tihamer Orban, et al.
The Journal of Experimental Medicine
|
April 7, 2004
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
Vissia Viglietta, Clare Baecher-Allan, Howard L Weiner, et al.
Clinical Therapeutics
|
May 23, 2015
Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate
John O'Gorman, Heidy K Russell, Jie Li, et al.
International Journal of MS Care
|
June 3, 2016
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Jonathan Calkwood, Timothy Vollmer, Robert J Fox, et al.
The Lancet. Neurology
|
March 15, 2011
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni, Stuart Cook, Kottil Rammohan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2005
Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells
Sally C Kent, Yahua Chen, Sue M Clemmings, et al.
Investigational New Drugs
|
March 12, 2020
Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients
Vissia Viglietta, Fuxin Shi, Qi-Ying Hu, et al.
Page
of 3